Stocks and Investing Stocks and Investing
Mon, December 12, 2022
Fri, December 9, 2022
Thu, December 8, 2022
Wed, December 7, 2022
Tue, December 6, 2022

Charles Duncan Downgraded (AVXL) to Hold and Decreased Target to $11 on, Dec 6th, 2022


Published on 2024-10-28 00:27:55 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Downgraded "Anavex Life Sciences Corp." (AVXL) to Hold and Decreased Target from $16 to $11 on, Dec 6th, 2022.

Charles, nor any peers, have made any analyst calls on AVXL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30